Luo, G.H., Shi, X.C., Yi, C., et al. (2019) Entacapone Can Effectively Improve the Diagnostic Efficacy of 18F-DOPA PET/CT for Parkinson’s Disease. Chinese Journal of Nuclear Medicine and Molecular Imaging, 39, 15-19.

has been cited by the following article:

• TITLE: Advances in Clinical Research of Imaging Technology for Parkinson’s Disease

  AUTHORS: Zhao Shen, Xiufen Yao

  KEYWORDS: Parkinson’s Disease, MRI, Ultrasound, Positron Emission Computed Tomography

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.8 No.8, August 10, 2020

  ABSTRACT: Parkinson currently lacks effective indicators for early diagnosis. The cause of the disease is mainly related to the degeneration of dopaminergic neurons in the dense part of the substantia nigra. By studying the changes in the substantia nigra, early Parkinson’s patients can be diagnosed by MRI, Ultrasound and Imaging techniques such as positron emission tomography. They have demonstrated the substantia nigra degeneration of Parkinson’s patients through many studies. This article reviews the research status of imaging techniques in the diagnosis of Parkinson’s disease, and hopes to provide more reliable basis to detect Parkinson’s disease.